Doctor profile · Federal record
Dr. Naim Nazha, M.D.
Medical Oncology Physician (CMS: Medical Oncology) · Northfield, NJ
- NPI 1730136854
- Accepts Medicare
- MIPS 85.9 / 100 · 2023
- 47 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
411 New RD
Northfield, NJ 082251648
(609) 383-6033
fax (609) 383-0064
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- November 3, 2009
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- New Jersey #25MA04569800
- Medicaid
- NJ #4020103
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1730136854. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
179,721
Distinct HCPCS
10
Medicare allowed
$3,539,626
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 46,920 | 14 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 34,600 | 20 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 19,860 | 119 | $23 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 15,680 | 31 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 12,278 | 109 | $0 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 8,380 | 24 | $28 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 7,931 | 90 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 3,330 | 45 | $1 | |
36415 |
Insertion of needle into vein for collection of blood sample | 2,940 | 667 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 2,914 | 658 | $8 |
In context: peer comparison
Among 1 peers in Northfield Medical Oncology Physician, average services per provider: 4,729. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$891
Transactions
33
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Shield Therapeutics INC | 3 | $283.10 | |
| Tempus Ai, INC | 5 | $109.50 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $86.35 | |
| Exelixis INC. | 4 | $71.55 | |
| Karyopharm Therapeutics INC. | 2 | $64.37 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $37.12 | |
| Rigel Pharmaceuticals, INC. | 2 | $34.43 | |
| Novartis Pharmaceuticals Corporation | 2 | $34.39 | |
| Immunocore Limited | 1 | $32.07 | |
| Abbvie INC. | 2 | $30.94 | |
| Adc Therapeutics America, INC. | 1 | $22.64 | |
| Janssen Biotech, INC. | 1 | $19.77 | |
| Blueprint Medicines Corporation | 1 | $17.87 | |
| BeiGene USA, INC. | 1 | $17.18 | |
| Servier Pharmaceuticals LLC | 1 | $15.58 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
773
Patients
209
Total drug cost
$1,286,293
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 189 | 51 | $6,453 |
| Ondansetron Hcl | Generic | 74 | 41 | $809 |
| Raloxifene Hcl | Generic | 69 | 15 | $4,068 |
| Eliquis (Apixaban) | Brand | 62 | 17 | $63,432 |
| Oxycodone Hcl | Generic | 59 | 0 | $716 |
| Anastrozole | Generic | 44 | 13 | $1,266 |
| Pantoprazole Sodium | Generic | 36 | 18 | $893 |
| Levothyroxine Sodium | Generic | 34 | 12 | $638 |
| Revlimid (Lenalidomide) | Brand | 34 | 0 | $636,979 |
| Imbruvica (Ibrutinib) | Brand | 33 | 0 | $565,936 |
Hospital affiliations
Frequently asked questions
What is Dr. Naim Nazha's medical specialty?
Dr. Naim Nazha practices Medical Oncology Physician in Northfield, NJ.
Where does Dr. Naim Nazha practice?
Dr. Naim Nazha practices at 411 New RD, Northfield, NJ 082251648. Office phone: 6093836033.
What is Dr. Naim Nazha's NPI?
Dr. Naim Nazha's National Provider Identifier (NPI) is 1730136854, issued by NPPES.
Does Dr. Naim Nazha accept Medicare assignment?
Yes. Dr. Naim Nazha accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Naim Nazha commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.